|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00002455 |
|
Date of registration:
|
01/11/1999 |
|
Primary sponsor: |
|
|
Public title:
|
Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma
|
|
Scientific title:
|
Immunotherapy of Colon Cancer With Autologous Perchloric Soluble Tumors Extracts |
|
Date of first enrolment:
|
April 1971 |
|
Target sample size:
|
|
|
Recruitment status: |
Active, not recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT00002455 |
|
Study type:
|
Interventional |
|
Study design:
|
Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
Argentina
| | | | | | | |
|
Contacts
|
|
Name:
|
Hugo Omar De Carli, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Centro Oncologico de Excelencia |
| | |
|
Key inclusion & exclusion criteria
|
DISEASE CHARACTERISTICS:
- Diagnosis of colon cancer, breast cancer, or melanoma with minimal residual disease
(at least 90% of tumor mass resected) after surgical resection
- Hormone receptor status:
- Not specified
PATIENT CHARACTERISTICS:
Age:
- 20 to 80
Sex:
- Not specified
Menopausal status:
- Not specified
Performance status:
- Not specified
Life expectancy:
- Not specified
Hematopoietic:
- Not specified
Hepatic:
- Not specified
Renal:
- Not specified
PRIOR CONCURRENT THERAPY:
Biologic therapy
- Not specified
Chemotherapy
- Not specified
Endocrine therapy
- Not specified
Radiotherapy
- Not specified
Surgery
- See Disease Characteristics
Age minimum:
20 Years
Age maximum:
80 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Breast Cancer
|
|
Colorectal Cancer
|
|
Melanoma (Skin)
|
|
Intervention(s)
|
|
Biological: Corynebacterium granulosum P40
|
|
Procedure: adjuvant therapy
|
|
Primary Outcome(s)
|
|
Recurrence
[Time Frame: No]
|
|
Response to study parameters
[Time Frame: No]
|
|
Survival rate
[Time Frame: No]
|
|
Secondary ID(s)
|
|
ARG-CO/BR-1
|
|
CDR0000072435
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|